STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Gain (Loss)
Beginning Balance at Dec. 31, 2021	$ 272,976	$ 4	$ 518,183	$ (245,108)	$ (103)
Beginning Balance (in shares) at Dec. 31, 2021		39,430,120
Exercise of common stock options	16		16
Exercise of common stock options (in shares)		8,482
Stock-based compensation expense	3,945		3,945
Unrealized gain (loss) on investments	(699)				(699)
Net loss	(23,159)			(23,159)
Ending Balance at Mar. 31, 2022	253,079	$ 4	522,144	(268,267)	(802)
Ending Balance (in shares) at Mar. 31, 2022		39,438,602
Beginning Balance at Dec. 31, 2021	272,976	$ 4	518,183	(245,108)	(103)
Beginning Balance (in shares) at Dec. 31, 2021		39,430,120
Unrealized gain (loss) on investments	(1,644)
Ending Balance at Sep. 30, 2022	214,819	$ 4	529,945	(313,383)	(1,747)
Ending Balance (in shares) at Sep. 30, 2022		39,576,047
Beginning Balance at Mar. 31, 2022	253,079	$ 4	522,144	(268,267)	(802)
Beginning Balance (in shares) at Mar. 31, 2022		39,438,602
Exercise of common stock options	61		61
Exercise of common stock options (in shares)		38,407
Issuance of common stock from ESPP	354		354
Issuance of common stock from ESPP (in shares)		98,445
Stock-based compensation expense	4,092		4,092
Unrealized gain (loss) on investments	(429)				(429)
Net loss	(20,287)			(20,287)
Ending Balance at Jun. 30, 2022	236,870	$ 4	526,651	(288,554)	(1,231)
Ending Balance (in shares) at Jun. 30, 2022		39,575,454
Exercise of common stock options	1		1
Exercise of common stock options (in shares)		593
Stock-based compensation expense	3,293		3,293
Unrealized gain (loss) on investments	(516)				(516)
Net loss	(24,829)			(24,829)
Ending Balance at Sep. 30, 2022	214,819	$ 4	529,945	(313,383)	(1,747)
Ending Balance (in shares) at Sep. 30, 2022		39,576,047
Beginning Balance at Dec. 31, 2022	$ 222,351	$ 5	557,867	(334,230)	(1,291)
Beginning Balance (in shares) at Dec. 31, 2022	45,089,537	45,089,537
Exercise of common stock options (in shares)		16
Issuance of common stock upon vesting of RSUs (in shares)		1,662
Stock-based compensation expense	$ 3,614		3,614
Unrealized gain (loss) on investments	792				792
Net loss	(23,945)			(23,945)
Ending Balance at Mar. 31, 2023	202,812	$ 5	561,481	(358,175)	(499)
Ending Balance (in shares) at Mar. 31, 2023		45,091,215
Beginning Balance at Dec. 31, 2022	$ 222,351	$ 5	557,867	(334,230)	(1,291)
Beginning Balance (in shares) at Dec. 31, 2022	45,089,537	45,089,537
Exercise of common stock options (in shares)	7,185
Unrealized gain (loss) on investments	$ 922
Ending Balance at Sep. 30, 2023	$ 247,414	$ 6	654,374	(406,597)	(369)
Ending Balance (in shares) at Sep. 30, 2023	54,540,715	54,540,715
Beginning Balance at Mar. 31, 2023	$ 202,812	$ 5	561,481	(358,175)	(499)
Beginning Balance (in shares) at Mar. 31, 2023		45,091,215
Issuance of common stock and pre-funded warrants, net	84,774	$ 1	84,773
Issuance of common stock and pre-funded warrants, net (in shares)		9,285,710
Issuance of common stock upon vesting of RSUs (in shares)		9,308
Issuance of common stock from ESPP	400		400
Issuance of common stock from ESPP (in shares)		145,938
Stock-based compensation expense	3,825		3,825
Unrealized gain (loss) on investments	(68)				(68)
Net loss	(22,944)			(22,944)
Ending Balance at Jun. 30, 2023	268,799	$ 6	650,479	(381,119)	(567)
Ending Balance (in shares) at Jun. 30, 2023		54,532,171
Exercise of common stock options	31		31
Exercise of common stock options (in shares)		7,169
Issuance of common stock upon vesting of RSUs (in shares)		1,375
Stock-based compensation expense	3,864		3,864
Unrealized gain (loss) on investments	198				198
Net loss	(25,478)			(25,478)
Ending Balance at Sep. 30, 2023	$ 247,414	$ 6	$ 654,374	$ (406,597)	$ (369)
Ending Balance (in shares) at Sep. 30, 2023	54,540,715	54,540,715